98%
921
2 minutes
20
Drug-drug interactions (DDIs) pose a major concern in polypharmacy due to their potential to cause unexpected side effects that can adversely affect a patient's health. Therefore, it is crucial to identify DDIs effectively during the early stages of drug discovery and development. In this paper, a novel DDI prediction network (DDINet) is proposed to enhance the predictive performance over conventional DDI methods. Leveraging the DrugBank dataset, drugs are represented using the Simplified Molecular Input Line-Entry System (SMILES), with the RDKit software pre-processing the SMILES strings into their canonical forms. Multiple molecular fingerprinting techniques such as Extended Connectivity Fingerprints (ECFPs), Molecular ACCess System keys (MACCSkeys), PubChem Fingerprints, 3D molecular fingerprints (3D-FP), and molecular dynamics fingerprints (MDFPs) are employed to encode drug chemical structures into feature vectors. Drug similarities are computed using the Tanimoto coefficient (TC), and the final Structural Similarity Profile (SSP) is obtained by averaging the five molecular fingerprint types. The novelty of the approach lies in the integration of a Multi-head Attention centered Weighted Autoencoder (Mul_WAE) as the interaction prediction module, which leverages the Multi-head Attention (MHA) layer to focus on the most significant input features. Furthermore, we introduce the Upgraded Bald Eagle Search Optimization (UBesO) algorithm, which optimally selects the learnable parameters of the Mul_WAE based on cross-entropy loss, improving the model's convergence and performance. The proposed DDINet model achieves an accuracy of 99.77%, 99.66% of AUC, 99.5% average precision, 99.4% precision, and 99.49% recall, providing a comprehensive evaluation of the model's robustness. Beyond high accuracy, DDINet offers advantages in scalability, making it well suited for handling large datasets due to its efficient feature extraction and optimization processes. The unique combination of multiple molecular fingerprinting methods with the MHA layer and UBesO algorithm highlights the innovative aspects of our model and significantly improves prediction performance compared to existing approaches.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1142/S0219720025500039 | DOI Listing |
Comput Methods Programs Biomed
August 2025
Zhengzhou University, School of Computer and Artificial Intelligence, Zhengzhou, 450001, China. Electronic address:
Background And Objective: The early detection of breast cancer plays a critical role in improving survival rates and facilitating precise medical interventions. Therefore, the automated identification of breast abnormalities becomes paramount, significantly enhancing the prospects of successful treatment outcomes. To address this imperative, our research leverages multiple modalities such as MRI, CT, and mammography to detect and screen for breast cancer.
View Article and Find Full Text PDFIEEE Trans Neural Netw Learn Syst
September 2025
In industrial scenarios, semantic segmentation of surface defects is vital for identifying, localizing, and delineating defects. However, new defect types constantly emerge with product iterations or process updates. Existing defect segmentation models lack incremental learning capabilities, and direct fine-tuning (FT) often leads to catastrophic forgetting.
View Article and Find Full Text PDFFront Med (Lausanne)
August 2025
College of Information Science and Technology, Hainan Normal University, Guilinyang Campus, Haikou, Hainan, China.
Introduction: Accurately predicting tumor cell line responses to therapeutic drugs is essential for personalized cancer treatment. Current methods using bulk cell data fail to fully capture tumor heterogeneity and the complex mechanisms underlying treatment responses.
Methods: This study introduces a novel method, ATSDP-NET (Attention-based Transfer Learning for Enhanced Single-cell Drug Response Prediction), which combines bulk and single-cell data.
Adv Sci (Weinh)
September 2025
School of Artificial Intelligence, Jilin University, Changchun, 130012, China.
Single-cell multi-omics technologies are pivotal for deciphering the complexities of biological systems, with Cellular Indexing of Transcriptomes and Epitopes by Sequencing (CITE-seq) emerging as a particularly valuable approach. The dual-modality capability makes CITE-seq particularly advantageous for dissecting cellular heterogeneity and understanding the dynamic interplay between transcriptomic and proteomic landscapes. However, existing computational models for integrating these two modalities often struggle to capture the complex, non-linear interactions between RNA and antibody-derived tags (ADTs), and are computationally intensive.
View Article and Find Full Text PDFIEEE J Biomed Health Inform
September 2025
The personalization of cancer treatment through drug combinations is critical for improving healthcare outcomes, increasing effectiveness, and reducing side effects. Computational methods have become increasingly important to prioritize synergistic drug pairs because of the vast search space of possible chemicals. However, existing approaches typically rely solely on global molecular structures, neglecting information exchange between different modality representations and interactions between molecular and fine-grained fragments, leading to limited understanding of drug synergy mechanisms for personalized treatment.
View Article and Find Full Text PDF